IONS - Company ID 0000874015
IONIS PHARMACEUTICALS INC (IONS) reported revenue of $943.71M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $943.71M | +33.8% |
| FY 2024 | $705.14M | -10.5% |
| FY 2023 | $787.65M | +34.1% |
| FY 2022 | $587.37M | -27.5% |
| FY 2021 | $810.46M | +11.1% |
| FY 2020 | $729.26M | -35.0% |
| FY 2019 | $1.12B | +87.2% |
| FY 2018 | $599.67M | +18.1% |
| FY 2017 |
IONIS PHARMACEUTICALS INC (IONS) reported revenue of $943.71M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, IONIS PHARMACEUTICALS INC's revenue grew from $99.09M to $943.71M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $507.67M |
| +46.5% |
| FY 2016 | $346.62M | +22.2% |
| FY 2015 | $283.70M | +32.5% |
| FY 2014 | $214.16M | +45.4% |
| FY 2013 | $147.28M | +44.3% |
| FY 2012 | $102.05M | +3.0% |
| FY 2011 | $99.09M | - |